Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „mirabegron“
Suchtreffer
Begriffe & Kennungen
Betmiga · 4.5 · 6 Caution is advised if mirabegron is co-administered with medicinal products with a narrow therapeutic index
Eintrag öffnenBetmiga · 4.5 · Caution is advised if mirabegron is co-administered with medicinal products with a narrow therapeutic index an
Eintrag öffnenBetmiga · 4.5 · Clinically relevant drug interactions between mirabegron and medicinal products that inhibit, induce or are a
Eintrag öffnenBetmiga · 4.5 · Clinically relevant drug interactions between mirabegron and medicinal products that inhibit, induce or are a
Eintrag öffnenBetmiga · 4.5 · Drug-drug interactions The effect of co-administered medicinal products on the pharmacokinetics of mirabegron
Eintrag öffnenBetmiga · 4.5 · Drug-drug interactions The effect of co-administered medicinal products on the pharmacokinetics of mirabegron
Eintrag öffnenBetmiga · 4.5 · Effect of enzyme inhibitors Mirabegron exposure (AUC) was increased 1.8-fold in the presence of the strong inh
Eintrag öffnenBetmiga · 4.5 · Effect of enzyme inhibitors Mirabegron exposure (AUC) was increased 1.8-fold in the presence of the strong inh
Eintrag öffnenBetmiga · 4.5 · Effect of mirabegron on CYP2D6 substrates In healthy volunteers, the inhibitory potency of mirabegron towards
Eintrag öffnenBetmiga · 4.5 · Effect of mirabegron on CYP2D6 substrates In healthy volunteers, the inhibitory potency of mirabegron towards
Eintrag öffnenBetmiga · 4.5 · Effect of mirabegron on transporters Mirabegron is a weak inhibitor of P-gp. Mirabegron increased Cmax and AUC
Eintrag öffnenBetmiga · 4.5 · Effect of mirabegron on transporters Mirabegron is a weak inhibitor of P-gp. Mirabegron increased Cmax and AUC
Eintrag öffnenBetmiga · 4.5 · Increases in mirabegron exposure due to drug-drug interactions may be associated with increases in pulse rate.
Eintrag öffnenBetmiga · 4.5 · Increases in mirabegron exposure due to drug-drug interactions may be associated with increases in pulse rate.
Eintrag öffnenBetmiga · 4.5 · Mirabegron is transported and metabolised through multiple pathways. Mirabegron is a substrate for cytochrome
Eintrag öffnenBetmiga · 4.5 · Mirabegron is transported and metabolised through multiple pathways. Mirabegron is a substrate for cytochrome
Eintrag öffnenBetmiga · 4.5 · Other interactions No clinically relevant interactions have been observed when mirabegron was co-administered
Eintrag öffnenBetmiga · 4.5 · Other interactions No clinically relevant interactions have been observed when mirabegron was co-administered
Eintrag öffnenBetmiga · 4.8 · 9 The safety of mirabegron tablets and oral suspension was evaluated in 26 paediatric patients aged 5 to less
Eintrag öffnenBetmiga · 4.8 · The most common adverse reactions reported for adult patients treated with mirabegron 50 mg during the three 1
Eintrag öffnen